Connecta Therapeutics
PrivateLast Round
Early Funding
Sep 10, 2026
Total Funding Raised
$16.83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Connecta Therapeutics is a biotechnology company developing new treatments for central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Connecta Therapeutics Comparables
Compare Connecta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Confluence Pharmaceuticals | 84% | |
| Nospharma | 80% | |
| Spinogenix, Inc. | 79% | |
Connecta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 10, 2026 | ||||
| Grant | Sep 9, 2025 | ||||
| Grant | Feb 12, 2024 | ||||
| Debt | Jun 6, 2023 | ||||
| Grant | Feb 3, 2022 | ||||
Seed | Jan 20, 2021 |
Key People
Founding team and executive leadership
Connecta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Early Funding, Seed |
| Inveready | Early Funding, Seed |
| Prous Institute for Biomedical Research | Early Funding, Seed |
| Clave Capital | Early Funding |
| Empresa Nacional de Innovación | Debt |
| Center for Technological Development and Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2026
$3.6M raised, led by Clave Capital.
- Aug 20, 2026
Monthly visitors grew 112% MoM.
Connecta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Connecta Therapeutics's valuation, stock price, and market status.